National drug regulator DCGI on May 1 approved 2-deoxy-D-glucose (2-DG) for emergency use as an adjunct therapy for Covid-19 patients with moderate or severe symptoms.

from Top Buzz News- News18.com https://ift.tt/3ysl8Ez
via IFTTT